Corneal melting associated with a fixed-dose combination of diclofenac 0.1% plus tobramycin 0.3% following cataract surgery.
Ornek
Kemal
K
Yalçindağ
Fatma N
FN
Ozdemir
Ozden
O
D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002387:Cataract Extraction; D003316:Corneal Diseases / Q000139:chemically induced*; D004008:Diclofenac / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D014031:Tobramycin / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D004008:Diclofenac; D014031:Tobramycin